The landscape of Multiple Myeloma Treatment is undergoing a transformative shift with the emergence of bispecific antibodies. These innovative therapies offer new hope for patients with relapsed or refractory multiple myeloma, providing an effective option when traditional treatments fail. As the field of oncology continues to evolve, bispecific antibodies are setting a new standard for...

The treatment landscape for multiple myeloma has undergone significant advancements recently, largely due to the introduction of novel drug classes like bispecific antibodies and CAR T (chimeric antigen receptor T-cell) therapies. These innovative treatments are reshaping how the disease is managed, offering hope for patients with R/R multiple myeloma, a group that has traditionally faced...